Pennant Group

Medicare Cuts, Workforce Strain Will Test Operations But Spark Resilience

AnalystLowTarget

Not Invested

Community Contributor

Published

10 Aug 25

AnalystLowTarget's Fair Value

US$28.00

13.0% undervalued

10 Sep

US$24.35

-27.9%

-5.8%

-27.9%

-5.8%

You can edit this narrative until Aug 10 10:13 PM. Then, changes will post as Updates.

Author's Valuation

US$2813.0% undervalued

AnalystLowTarget Fair Value

Narrative

Updates0

AnalystLowTarget Fair Value

US$28

13.0% undervalued

Future estimation in

% p.a.

Decrease

Increase

Current revenue growth rate

12.59%

Healthcare Services revenue growth rate

0.23%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

6.78%

Calculation

US$58.51m

Earnings '28

20.39x

PE Ratio '28

US$1.19b

Market Cap '28

US$1.19b

Market Cap '28

35.21m

No. shares '28

US$33.88

Share Price '28

US$33.88 Share Price '28

Discounted to 2025 @ 6.78% p.a.

US$27.83

Fair Value '25